{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:37:00Z","timestamp":1776339420997,"version":"3.51.2"},"reference-count":100,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:p>There is substantial evidence from studies in humans and animal models for a role of the endocannabinoid system in the control of emotional states. Several studies have shown an association between exposure to trauma and substance use. Specifically, it has been shown that there is increased prevalence of cannabis use in post-traumatic stress disorder (PTSD) patients and <jats:italic toggle=\"yes\">vice versa<\/jats:italic>. Clinical studies suggest that PTSD patients may cope with their symptoms by using cannabis. This treatment-seeking strategy may explain the high prevalence of cannabis use among individuals with PTSD. Preliminary studies in humans also suggest that treatment with cannabinoids may decrease PTSD symptoms including sleep quality, frequency of nightmares, and hyperarousal. However, there are no large-scale, randomized, controlled studies investigating this specifically. Studies in animal models have shown that cannabinoids can prevent the effects of stress on emotional function and memory processes, facilitate fear extinction, and have an anti-anxiety-like effect in a variety of tasks. Moreover, cannabinoids administered shortly after exposure to a traumatic event were found to prevent the development of PTSD-like phenotype. In this article, we review the existing literature on the use of cannabinoids for treating and preventing PTSD in humans and animal models. There is a need for large-scale clinical trials examining the potential decrease in PTSD symptomatology with the use of cannabis. In animal models, there is a need for a better understanding of the mechanism of action and efficacy of cannabis. Nevertheless, the end result of the current clinical and preclinical data is that cannabinoid agents may offer therapeutic benefits for PTSD.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000253","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T15:36:49Z","timestamp":1471966609000},"page":"561-569","source":"Crossref","is-referenced-by-count":41,"title":["Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention"],"prefix":"10.1097","volume":"27","author":[{"given":"Tomer","family":"Mizrachi Zer-Aviv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Segev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irit","family":"Akirav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230910","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/hipo.20711","article-title":"Cannabinoids modulate hippocampal memory and plasticity","volume":"20","author":"Abush","year":"2010","journal-title":"Hippocampus"},{"key":"R2-20230910","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0306-4522(90)90244-X","article-title":"Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system","volume":"39","author":"Ahima","year":"1990","journal-title":"Neuroscience"},{"key":"R3-20230910","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fnbeh.2011.00034","article-title":"The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus","volume":"5","author":"Akirav","year":"2011","journal-title":"Front Behav Neurosci"},{"issue":"Pt 2","key":"R4-20230910","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.neubiorev.2013.08.002","article-title":"Cannabinoids and glucocorticoids modulate emotional memory after stress","volume":"37","author":"Akirav","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"R5-20230910","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neuroscience.2011.08.047","article-title":"Role of the endocannabinoid system in regulating glucocorticoid effects on memory for emotional experiences","volume":"204","author":"Atsak","year":"2012","journal-title":"Neuroscience"},{"key":"R6-20230910","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1016\/j.lfs.2004.06.006","article-title":"The role of endogenouscannabinoids in the hypothalamo\u2013pituitary\u2013adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice","volume":"75","author":"Barna","year":"2004","journal-title":"Life Sci"},{"key":"R7-20230910","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pnpbp.2008.12.004","article-title":"Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review","volume":"33","author":"Berger","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R8-20230910","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jts.20243","article-title":"Posttraumatic stress symptom severity predicts marijuana use coping motives among 649 traumatic event exposed marijuana users","volume":"20","author":"Bonn-Miller","year":"2007","journal-title":"J Trauma Stress"},{"key":"R9-20230910","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/15504261003751887","article-title":"Sleep problems and PTSD symptoms interact to predict marijuana use coping motives: a preliminary investigation","volume":"6","author":"Bonn-Miller","year":"2010","journal-title":"J Dual Diagnosis"},{"key":"R10-20230910","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.drugalcdep.2013.12.008","article-title":"Using cannabis to help you sleep: heightened frequency of medical cannabis use among those with PTSD","volume":"136","author":"Bonn-Miller","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"R11-20230910","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1176\/ajp.153.3.369","article-title":"Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse","volume":"153","author":"Bremner","year":"1996","journal-title":"Am J Psychiatry"},{"key":"R12-20230910","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0306-4530(00)00058-5","article-title":"Enhanced memory for emotional material following stress-level cortisol treatment in humans","volume":"26","author":"Buchanan","year":"2001","journal-title":"Psychoneuroendocrinology"},{"key":"R13-20230910","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.addbeh.2011.08.009","article-title":"Marijuana use among traumatic event-exposed adolescents: posttraumatic stress symptom frequency predicts coping motivations for use","volume":"37","author":"Bujarski","year":"2012","journal-title":"Addict Behav"},{"key":"R14-20230910","first-page":"24","article-title":"Primary prevention of posttraumatic stress disorder: drugs and implications","volume":"2","author":"Burbiel","year":"2015","journal-title":"Mil Med Res"},{"key":"R15-20230910","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2012.11.016","article-title":"Predator threat stress promotes long lasting anxiety-like behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD symptoms","volume":"533","author":"Campos","year":"2013","journal-title":"Neurosci Lett"},{"key":"R16-20230910","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/sj.npp.1300655","article-title":"Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear","volume":"30","author":"Chhatwal","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"R17-20230910","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.biopsych.2008.05.025","article-title":"Early post-stressor intervention with high-dose corticosterone attenuates posttraumatic stress response in an animal model of posttraumatic stress disorder","volume":"64","author":"Cohen","year":"2008","journal-title":"Biol Psychiatry"},{"key":"R18-20230910","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1037\/a0023076","article-title":"Posttraumatic stress disorder and cannabis use in a nationally representative sample","volume":"25","author":"Cougle","year":"2011","journal-title":"Psychol Addict Behav"},{"key":"R19-20230910","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.nurx.2005.12.008","article-title":"Pharmacological treatments that facilitate extinction of fear: relevance to psychotherapy","volume":"3","author":"Davis","year":"2006","journal-title":"NeuroRx"},{"key":"R20-20230910","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.neuropharm.2012.05.039","article-title":"A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers","volume":"64","author":"De Bitencourt","year":"2013","journal-title":"Neuropharmacology"},{"key":"R21-20230910","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.neuroscience.2008.05.005","article-title":"Opposite action of hippocampal CB1 receptors in memory reconsolidation and extinction","volume":"154","author":"De Oliveira Alvares","year":"2008","journal-title":"Neuroscience"},{"key":"R22-20230910","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.yfrne.2009.03.002","article-title":"Glucocorticoids and the regulation of memory in health and disease","volume":"30","author":"De Quervain","year":"2009","journal-title":"Front Neuroendocrinol"},{"key":"R23-20230910","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13104-016-1988-4","article-title":"Cannabis use among Navy personnel in Sri Lanka: a cross sectional study","volume":"9","author":"De Silva","year":"2016","journal-title":"BMC Res Notes"},{"key":"R24-20230910","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.drugalcdep.2010.11.032","article-title":"What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews","volume":"117","author":"Degenhardt","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"R25-20230910","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0006-3223(00)00896-9","article-title":"Initial posttraumatic urinary cortisol levels predict subsequent PTSD symptoms in motor vehicle accident victims","volume":"48","author":"Delahanty","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R26-20230910","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"R27-20230910","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1523\/JNEUROSCI.23-12-04850.2003","article-title":"Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism","volume":"23","author":"Di","year":"2003","journal-title":"J Neurosci"},{"key":"R29-20230910","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbr.2013.04.045","article-title":"Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptors","volume":"250","author":"Do Monte","year":"2013","journal-title":"Behav Brain Res"},{"key":"R30-20230910","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1517\/14656566.9.15.2727","article-title":"Is rimonabant efficacious and safe in the treatment of obesity?","volume":"9","author":"Doggrell","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"R31-20230910","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1176\/appi.ajp.2007.07030504","article-title":"Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia","volume":"164","author":"Etkin","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R32-20230910","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.euroneuro.2015.12.037","article-title":"The association between cannabis use and anxiety disorders: Results from a population-based representative sample","volume":"26","author":"Feingold","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"R33-20230910","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0006-3223(02)01552-4","article-title":"Context in the clinic: how well do cognitive-behavioral therapies and medications work in combination?","volume":"52","author":"Foa","year":"2002","journal-title":"Biol Psychiatry"},{"key":"R34-20230910","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1755-5949.2008.00071.x","article-title":"The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD)","volume":"15","author":"Fraser","year":"2009","journal-title":"CNS Neurosci Ther"},{"key":"R35-20230910","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol Rev"},{"key":"R36-20230910","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1196\/annals.1364.010","article-title":"Toward a psychobiology of posttraumatic self-dysregulation: reexperiencing, hyperarousal, dissociation, and emotional numbing","volume":"1071","author":"Frewen","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"R38-20230910","doi-asserted-by":"crossref","first-page":"11078","DOI":"10.1523\/JNEUROSCI.1223-09.2009","article-title":"Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance","volume":"29","author":"Ganon-Elazar","year":"2009","journal-title":"J Neurosci"},{"key":"R39-20230910","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/npp.2011.204","article-title":"Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress","volume":"37","author":"Ganon-Elazar","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"R40-20230910","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.psyneuen.2013.01.014","article-title":"Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit","volume":"38","author":"Ganon-Elazar","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"R41-20230910","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/mp.2012.72","article-title":"Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity","volume":"18","author":"Gunduz-Cinar","year":"2013a","journal-title":"Mol Psychiatry"},{"key":"R42-20230910","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tips.2013.08.008","article-title":"Amygdala FAAH and anandamide: mediating protection and recovery from stress","volume":"34","author":"Gunduz-Cinar","year":"2013b","journal-title":"Trends Pharmacol Sci"},{"key":"R43-20230910","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1460-9568.2002.02192.x","article-title":"The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety","volume":"16","author":"Haller","year":"2002","journal-title":"Eur J Neurosci"},{"key":"R44-20230910","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00213-009-1494-7","article-title":"Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats","volume":"204","author":"Haller","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"R45-20230910","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/1606635021000041807","article-title":"Cannabis effects and dependency concerns in long-term frequent users: a missing piece of the public health puzzle","volume":"11","author":"Hathaway","year":"2003","journal-title":"Addict Res Theory"},{"key":"R46-20230910","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 7","key":"R47-20230910","first-page":"5","article-title":"Posttraumatic stress disorder: epidemiology and health-related considerations","volume":"61","author":"Hidalgo","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R48-20230910","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/187152709789824624","article-title":"The endocannabinoid system and the treatment of mood and anxiety disorders","volume":"8","author":"Hill","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"R49-20230910","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuroscience.2011.12.030","article-title":"Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis","volume":"204","author":"Hill","year":"2012","journal-title":"Neuroscience"},{"key":"R50-20230910","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1038\/npp.2009.114","article-title":"Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis","volume":"34","author":"Hill","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"R51-20230910","doi-asserted-by":"crossref","first-page":"9406","DOI":"10.1073\/pnas.0914661107","article-title":"Endogenous cannabinoid signaling is essential for stress adaptation","volume":"107","author":"Hill","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"R52-20230910","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/mp.2012.90","article-title":"Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure","volume":"18","author":"Hill","year":"2013","journal-title":"Mol Psychiatry"},{"key":"R53-20230910","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psyneuen.2014.11.002","article-title":"The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: a preliminary randomized, double-blind, placebo-controlled cross-over design study","volume":"51","author":"Jetly","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"R54-20230910","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1523\/JNEUROSCI.21-23-09506.2001","article-title":"Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission","volume":"21","author":"Katona","year":"2001","journal-title":"J Neurosci"},{"key":"R55-20230910","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/archpsyc.1995.03950240066012","article-title":"Posttraumatic stress disorder in the National Comorbidity Survey","volume":"52","author":"Kessler","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"R56-20230910","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1037\/adb0000110","article-title":"Associations among trauma, posttraumatic stress disorder, cannabis use, and cannabis use disorder in a nationally representative epidemiologic sample","volume":"29","author":"Kevorkian","year":"2015","journal-title":"Psychol Addict Behav"},{"issue":"Suppl","key":"R57-20230910","first-page":"3","article-title":"The chemistry of endocannabinoids","volume":"29","author":"Kogan","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"R58-20230910","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1038\/npp.2014.132","article-title":"Cannabinoids prevent the effects of a footshock followed by situational reminders on emotional processing","volume":"39","author":"Korem","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"R59-20230910","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.phrs.2007.09.006","article-title":"The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction","volume":"56","author":"Lafen\u0119tre","year":"2007","journal-title":"Pharmacol Res"},{"key":"R60-20230910","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0006-3223(98)00246-7","article-title":"Brain activation in PTSD in response to trauma-related stimuli","volume":"45","author":"Liberzon","year":"1999","journal-title":"Biol Psychiatry"},{"key":"R61-20230910","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/cercor\/bhn075","article-title":"The role of prefrontal cortex CB1 receptors in the modulation of fear memory","volume":"19","author":"Lin","year":"2009","journal-title":"Cereb Cortex"},{"key":"R62-20230910","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.pbb.2005.02.017","article-title":"Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions","volume":"81","author":"Lundqvist","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"R63-20230910","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12035-007-8004-x","article-title":"The endocannabinoid system and extinction learning","volume":"36","author":"Lutz","year":"2007","journal-title":"Mol Neurobiol"},{"key":"R64-20230910","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.coph.2008.12.001","article-title":"Endocannabinoid signals in the control of emotion","volume":"9","author":"Lutz","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"R65-20230910","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fnbeh.2011.00063","article-title":"Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects","volume":"5","author":"Marco","year":"2011","journal-title":"Front Behav Neurosci"},{"key":"R67-20230910","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"key":"R68-20230910","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00213-001-0946-5","article-title":"Involvement of CB1 cannabinoid receptors in emotional behaviour","volume":"159","author":"Martin","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl 1","key":"R69-20230910","first-page":"S5","article-title":"Endocannabinoids and psychiatric disorders: the road ahead","volume":"32","author":"Mechoulam","year":"2010","journal-title":"Rev Bras Psiquiatr"},{"key":"R70-20230910","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","article-title":"Cannabidiol: an overview of some pharmacological aspects","volume":"42","author":"Mechoulam","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"R71-20230910","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1196\/annals.1401.006","article-title":"The role of the orbitofrontal cortex in anxiety disorders","volume":"1121","author":"Milad","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R72-20230910","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/7854_2009_16","article-title":"Cannabinoids and anxiety","volume":"2","author":"Moreira","year":"2010","journal-title":"Curr Top Behav Neurosci"},{"key":"R73-20230910","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.nlm.2013.12.010","article-title":"The endocannabinoid system: an emotional buffer in the modulation of memory function","volume":"112","author":"Morena","year":"2014","journal-title":"Neurobiol Learn Mem"},{"key":"R74-20230910","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00001756-199701200-00023","article-title":"Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat","volume":"8","author":"Navarro","year":"1997","journal-title":"Neuroreport"},{"key":"R75-20230910","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/mp.2013.61","article-title":"Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study","volume":"18","author":"Neumeister","year":"2013","journal-title":"Mol Psychiatry"},{"key":"R76-20230910","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1007\/s12272-015-0548-0","article-title":"Glucocorticoid- and long-term stress-induced aberrant synaptic plasticity are mediated by activation of the glucocorticoid receptor","volume":"38","author":"Park","year":"2015","journal-title":"Arch Pharm Res"},{"key":"R77-20230910","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.npp.1300535","article-title":"Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala","volume":"30","author":"Patel","year":"2005a","journal-title":"Neuropsychopharmacology"},{"key":"R78-20230910","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1460-9568.2005.03916.x","article-title":"Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling","volume":"21","author":"Patel","year":"2005b","journal-title":"Eur J Neurosci"},{"key":"R79-20230910","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"R80-20230910","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.nlm.2012.03.003","article-title":"Cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala prevent the stress-induced enhancement of a negative learning experience","volume":"97","author":"Ramot","year":"2012","journal-title":"Neurobiol Learn Mem"},{"key":"R81-20230910","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/10253890.2011.586753","article-title":"Endocannabinoids and stress","volume":"14","author":"Riebe","year":"2011","journal-title":"Stress"},{"key":"R82-20230910","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40261-014-0212-3","article-title":"Preliminary, open-label, pilot study of add-on oral \u03949-tetrahydrocannabinol in chronic post-traumatic stress disorder","volume":"34","author":"Roitman","year":"2014","journal-title":"Clin Drug Investig"},{"key":"R83-20230910","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/nlme.1996.3765","article-title":"Glucocorticoid receptor agonist and antagonist administration into the basolateral but not central amygdala modulates memory storage","volume":"67","author":"Roozendaal","year":"1997","journal-title":"Neurobiol Learn Mem"},{"key":"R84-20230910","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2337\/dc08-0386","article-title":"SERENADE: the Study Evaluating Rimonabant Efficacy in Drug-naive Diabetic Patients: effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes","volume":"31","author":"Rosenstock","year":"2008","journal-title":"Diabetes Care"},{"key":"R85-20230910","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1124\/mol.110.064196","article-title":"Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition","volume":"78","author":"Rossi","year":"2010","journal-title":"Mol Pharmacol"},{"key":"R86-20230910","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/cbdv.200790150","article-title":"Cannabis, pain, and sleep: lessons from 651 therapeutic clinical trials of Sativex, a cannabis-based medicine","volume":"4","author":"Russo","year":"2007","journal-title":"Chem Biodivers"},{"issue":"Suppl 1","key":"R87-20230910","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2826.2008.01681.x","article-title":"CB1 receptor blockade and its impact on cardiometabolic risk factors: overview of the RIO programme with rimonabant","volume":"20","author":"Scheen","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"R88-20230910","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/npp.2015.238","article-title":"Cannabinoids and glucocorticoids in the basolateral amygdala modulate hippocampal-accumbens plasticity after stress","volume":"41","author":"Segev","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"R89-20230910","doi-asserted-by":"crossref","first-page":"e29988","DOI":"10.1371\/journal.pone.0029988","article-title":"Stress hormones receptors in the amygdala mediate the effects of stress on the consolidation, but not the retrieval, of a non aversive spatial task","volume":"7","author":"Segev","year":"2012","journal-title":"PLoS One"},{"key":"R90-20230910","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/npp.2013.292","article-title":"Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression","volume":"39","author":"Segev","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"R91-20230910","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1196\/annals.1364.007","article-title":"Amygdala, medial prefrontal cortex, and hippocampal function in PTSD","volume":"1071","author":"Shin","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"R93-20230910","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.drugalcdep.2015.12.014","article-title":"Marijuana dependence moderates the effect of posttraumatic stress disorder on trauma cue reactivity in substance dependent patients","volume":"159","author":"Tull","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"R94-20230910","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.neuropharm.2004.01.003","article-title":"Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors","volume":"46","author":"Urig\u00fcen","year":"2004","journal-title":"Neuropharmacology"},{"issue":"Suppl 2","key":"R95-20230910","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.2337\/dc08-s258","article-title":"Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight\/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program","volume":"31","author":"Van Gaal","year":"2008","journal-title":"Diabetes Care"},{"key":"R96-20230910","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pbb.2005.01.029","article-title":"Endocannabinoid system and stress and anxiety responses","volume":"81","author":"Viveros","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"R97-20230910","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000126646","article-title":"Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat","volume":"59","author":"Weidenfeld","year":"1994","journal-title":"Neuroendocrinology"},{"key":"R98-20230910","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1389557054368763","article-title":"Role of endogenous cannabinoids in cognition and emotionality","volume":"5","author":"Wotjak","year":"2005","journal-title":"Mini Rev Med Chem"},{"key":"R99-20230910","article-title":"The use of medicinal marijuana for posttraumatic stress disorder: a review of the current literature","volume":"17","author":"Yarnell","year":"2015","journal-title":"Prim Care Companion CNS Disord"},{"key":"R100-20230910","first-page":"23","article-title":"Posttraumatic stress disorder in the general population and in children","volume":"62","author":"Yule","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R101-20230910","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fnbeh.2011.00057","article-title":"Effects of endocannabinoid system modulation on cognitive and emotional behavior","volume":"5","author":"Zanettini","year":"2011","journal-title":"Front Behav Neurosci"},{"key":"R102-20230910","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/hipo.22577","article-title":"Sex differences in hippocampal response to endocannabinoids after exposure to severe stress","volume":"26","author":"Zer-Aviv","year":"2016","journal-title":"Hippocampus"},{"key":"R103-20230910","doi-asserted-by":"crossref","first-page":"301","DOI":"10.31887\/DCNS.2011.13.2\/jzohar","article-title":"New insights into secondary prevention in post-traumatic stress disorder","volume":"13","author":"Zohar","year":"2011","journal-title":"Dialogues Clin Neurosci"},{"key":"R104-20230910","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2125.2008.03329.x","article-title":"Biomarkers for the effects of 654 cannabis and THC in healthy volunteers","volume":"67","author":"Zuurman","year":"2009","journal-title":"Brit J Clin Pharmacol"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008877-201610000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T08:02:09Z","timestamp":1694332929000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201610000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":100,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000253","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}